ẢNH HƯỞNG CỦA DỊCH TRÍCH RAU DỆU (Alternanthera sessilis) LÊN SỰ ỨC CHẾ HÌNH THÀNH VÀ LÀM TAN TINH THỂ CANXI OXALAT GÂY BỆNH SỎI THẬN IN VITRO
Trung tâm Công nghệ sinh học tỉnh An Giang
Tỉnh lộ 941, ấp Vĩnh Phước, Thị trấn Vĩnh Bình, huyện Châu Thành, tỉnh An Giang
Số điện thoại: 0988202055; Email: ngphamtuan1983@gmail.com
Nội dung chính của bài viết
Tóm tắt
INHIBITION OF THE FORMATION AND DISSOLUTION OF CANXI OXALATE CRYSTALS CAUSING KIDNEY STONES BY AN EXTRACT OF Alternanthera sessilis IN VITRO
This study on using Alternanthera sessilis extract to inhibit the formation and to dissolue of canxi oxalate (CaOx) was conducted in vitro. The plant samples were extracted with ethanol 70% v/v. The content of phenolic and flavonoid of Alternanthera sessilis extract was determined by UV- Vis spectrophotometer at 510 nm and 765 nm. The inhibitory percentage of nucleation, growth and aggregation of CaOx was determined by UV- Vis spectrophotometer at 620 nm and 214 nm. Efficiencies in the dissolution of the canxi oxalat crystals of A. sessilis extract was determined by titration method. The results showed that moisture and the yield of Alternanthera sessilis extract were 15.98% and 7.22%, respectively. The extract of Alternanthera sessilis had the presence of bioactive compounds such as alkaloid, flavonoid, saponin, terpenoid, tannin and phenol. The phenolic and flavonoid content of Alternanthera sessilis extract were 167.79-320.65 mg gallic acid/g and 128.01-247.64 mg quercetin/g, respectively. The extract Alternanthera sessilis had the ability to inhibit nucleation, growth and aggregation of CaOx crystals and IC50 value of extract was 3.17 mg/mL; 2.48 mg/mL and 1.57 mg/mL, respectively. At 50 mg/mL of extract, Alternanthera sessilis extract have the ability to dissolue of the CaOx crystals reach 58.97%.
Từ khóa
Aggregation, dissolution, canxi oxalat, growth, kidney stone, nucleation, Alternanthera sessilis, rau dệu, sỏi thận, ngưng tụ, làm tan
Chi tiết bài viết
Tài liệu tham khảo
2. Evan A. P., Lingeman J. E., Coe F. L., Parks J. H., Bledsoe S. B., Shao Y., Sommer A. J., Paterson R. F., Kuo R. I. and Grynpas M., Randall’s plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle, J. Clin. Invest., 2003, 111:607-616.
3. Babu M., K. H. Uma, S. Joseph, A. Sree, S. Scariya, K. A. Shibina and J. Hameed., In-vitro evaluation of anti-urolithiatic and larvicidal activity of Alternanthera sessilis, Biomedical & Pharmacology Journal, 2021, 14(2):671-680.
4. Đỗ Huy Bích, Cây thuốc và động vật làm thuốc ở Việt Nam, Nhà xuất bản Khoa học và Kỹ Thuật, 2006.
5. Yadav M., S. Chatterji, Gupta S. K. and Watal G., Preliminary phytochemical screening of six medicinal plants used in traditional medicine, International Journal of Pharmacy and Pharmaceutical Sciences, 2014, 6(5):539-542.
6. Pieme C. A., Kumar S.G., Dongmo M. S., Ngogang J. Y. and Saxena A. K., Antiproliferative activity and induction of apoptosis by Annona muricata (Annonaceae) extract on human cancer cells, BMC complementary and alternative medicine, 2014, 14(1):1-10.
7. Yadav R. N. S. and Agarwala M., Phytochemical analysis of some medicinal plants, Journal of Phytology, 2011, 3:10-14.
8. Phatak R. S., and Hendre A. S., In-vitro antiurolithiatic activity of Kalanchoe pinnata extract, International Journal of Pharmacognosy and Phytochemical Research, 2015, 7:275-279.
9. Chaudhary A., Singla S. K. and Tandon C., In vitro evaluation of Terminalia arjuna on canxi phosphate and canxi oxalate crystallization, Indian Journal of Pharmaceutical Sciences, 2010, 72(3):340-345.
10. Saha S., and Ramtej J. V., Inhibition of canxi oxalate crystallisation in vitro by an extract of Bergenia ciliate, Arab J. of Urology, 2013, 11:187-192.
11. Saso L., G. Valentini and B. Silvestrini., Development of an in vitro assay for the screening of substances capable of dissolving canxi oxalate crystals, Urologia internationalis, 1999, 61(4):210-214.
12. Zarrow M. X., Experimental endocrinology: a sourcebook of basic techniques, Elsevier, 2012, p. 387-389.
13. Bandar H., A. Hijazi, H. Rammal, A. Hachem, A., Z. Saad & Badran B., Techniques for the extraction of bioactive compounds from Lebanese Urtica Dioica, American Journal of Phytomedicine and Clinical Therapeutics, 2013, 1(6):507-513.
14. Ravi S., Kaleena P. K., Babu M., Janaki A., Velu K. and Elumalai D., Phytochemical screening, antioxidant and anticancer potential of Imperata cylindrica (L.) raeusch against human breast cancer cell line (MCF-7), International Journal of Pharmacy and Biological Sciences, 2018, 8(3):938-945.
15. Saranya R., and Geetha N., Inhibition of canxi oxalate (CaOx) crystallization in vitro by the extract of beet root (Beta vulgais L.), International J. of Pharmacy and Pharmaceutical Sciences, 2014, 6(2):361-365.
16. Soon-suk L., K. Kwang, Lee., Composition and contents of free amino acids and phenolic acid and flavonoids of Imperata cylindrica Beauvois var. koenigii root extracts, Journal of Digital Convergence, 2020, 18(7):397-403.
17. Nirmaladevi R., D. Kavitha, & Padma P. R., Evaluation of antilithiatic potential of Hibiscus rosa-sinensis Linn, in vitro, Journal of Pharmacy Research, 2012, 5(8):4353-4356.
18. Kalpana S., T. S. Rai & R. Niramaladevi, Effect of Tridax procumbens extract on canxi oxalate crystallization under in vitro conditions, Advances in Applied Science Research, 2014, 5(3):411-416.
19. Agarwal K., & Varma R., In-vitro Canxi oxalate crystallization inhibition by Achyranthes aspera L. and Bryophyllum pinnatum Lam, British Journal of Pharmaceutical Research, 2015, 5(2):146-153.
20. Vyawahare J. N., Shelke P. A., & Baheti D. G., Inhibition of canxi oxalate crystallization in vitro by extract of Momordica charantia Linn, International Journal Of Pharmaceutical And Chemical Sciences, 2014, 3(2):448-452.